Details of the Drug Combinations

General Information of This Drug (ID: DMCRGY4)

Drug Name

Karenitecin DMCRGY4

Synonyms

Karenitecin (TN)

Indication

Disease Entry	ICD 11	Status	REF
Lung cancer	2C25.0	Phase 3	[1]
Ovarian cancer	2C73	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Karenitecin + Valproic Acid	DC6L3OW	Valproic Acid	Malignant Melanoma	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00477282) Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT00358319) Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma